REFERENCES
- Dahl, E. & Tveter, K. J. 1974. The ultrastructure of the accessory sex organs of the male rat. V. Effect of the antiandrogen compound Cyproterone acetate. J Endocrin 62, 251.
- Geller, J., Fishman, J. & Cantor, T. L. 1975. Effect of Cyproterone acetate on clinical, endocrine and pathological features of benign prostatic hypertrophy. J Steroid Biochem 6, 837.
- Hansson, V. & Tveter, K. J. 1971. Effect of anti-androgens on the uptake and binding of androgen by human benign nodular prostatic hyperplasia in vitro. Acta Endocr (Kbh.) 68. 69.
- Huggins, C. & Hodges, C. V. 1941. Studies on prostatic cancer: Effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of prostate. Cancer Res 1, 293.
- Jameson, R. M. 1976. Regression of penile metastases of prostatic carcinoma with Cyproterone acetate therapy. Br J Urol 48, 268.
- Neumann, F., von Berswordt-Wallrabe, R., Elger, W. & Steinbeck, H. 1970. Aspects of androgen-dependent events as studied by antiandrogens. Recent Progr Horm Res 26, 337.
- Scott, W. W. & Wade, J. C. 1969. Medical treatment of benign nodular prostatic hyperplasia with Cyproterone acetate. J Urol 101, 81.
- Smith, R. B., Walsh, P. C. & Goodwin, W. E. 1973. Cyproterone acetate in the treatment of advanced carcinoma of the prostate. J Urol 110, 106.
- Steinbeck, H., Mehring, M. & Neumann, F. 1971. Comparison of the effects of Cyproterone. Cyproterone acetate and estradiol on testicular function, accessory sexual glands and fertility in a long-term study on rats. J Reprod Fertil 26, 651.
- The Veterans Administration Cooperative Urological Research Group, 1967. Treatment and survival of patients with cancer of the prostate. Surg Gynecol Obstet 124, 1011.
- Wein, A. J. & Murphy, J. J. 1973. Experience in the treatment of prostatic carcinoma with Cyproterone acetate. J Urol 109, 68.